Policy & Regulation
18 September 2025 - Chinese pharmaceutical company Ascletis Pharma Inc (HKEX:1672) announced on Wednesday that the oral presentation of the Phase III study results of denifanstat (ASC40) for the treat...
18 September 2025 - CARsgen Therapeutics Holdings Limited (HK:2171), a China-based company involved in developing innovative CAR T-cell therapies, announced on Wednesday that the updated long-term fol...
18 September 2025 - CorestemChemon Inc (KOSDAQ:166480), a South Korea-based biotech company, announced on Wednesday that it has presented key findings from the Phase 3 ALSummit trial of Neuronata-R (l...
18 September 2025 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) and its US partner Ollin Biosciences on Thursday announced a clinical update on IBI324 (Ollin R&D code: OL...
17 September 2025 - Biopharmaceutical company AstraZeneca plc (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Wednesday that its Phase III TULIP-SC trial of Saphnelo (anifrolumab) met its primary end...
17 September 2025 - South Korean biopharmaceutical company Alteogen Inc. (KOSDAQ:196170) announced on Wednesday that the European Commission has granted marketing authorisation for EYLUXVI (ALT-L9), a...